BTS Guideline for the Investigation and Management of Pleural Mesothelioma
The new BTS Guideline for the investigation and management of pleural mesothelioma has been published.
The new Guideline provides recommendations relating to key points in the patient pathway, from optimal diagnostic strategies for suspected MPM, symptom control, anticancer treatment, follow-up and organisation of services.
The full guideline is published as a supplement to the March 2018 issue of Thorax (available below). A summary of the recommendations is also available in BMJ Open Respiratory Research (available below). Read the Thorax article online here
Declarations of Interest:
BTS Guideline Group members adhere to the BTS Policy for Working with the Biomedical Industry and complete an annual declaration of interest form during the period that the Guideline Group is active. Declarations of Interest for this BTS Guideline Group and the BTS Policy document are both available here.
|BTS Guideline for the investigation and management of malignant pleural mesothelioma||2018-02 February February 2018||
The BTS Guideline for the investigation and management of malignant pleural mesothelioma has been published online and as a supplement to the March 2018 issue of Thorax
|BTS Guideline for the investigation and management of mesothelioma - Summary of reccommendations||2018-02 February February 2018||Valid|
|Web Appendix 1 BTS mesothelioma guideline literature searches||2018-02 February February 2018||Valid|
|Web Appendix 2 BTS mesothelioma evidence tables||2018-02 February February 2018||Valid|
|BTS Guideline for the investigation and management of mesothelioma slides||2018-02 February February 2018||Valid|